We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CMD Bioscience and Research Foundation of SUNY on Behalf of Stony Brook University Sign Exclusive Licensing Agreement
News

CMD Bioscience and Research Foundation of SUNY on Behalf of Stony Brook University Sign Exclusive Licensing Agreement

CMD Bioscience and Research Foundation of SUNY on Behalf of Stony Brook University Sign Exclusive Licensing Agreement
News

CMD Bioscience and Research Foundation of SUNY on Behalf of Stony Brook University Sign Exclusive Licensing Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "CMD Bioscience and Research Foundation of SUNY on Behalf of Stony Brook University Sign Exclusive Licensing Agreement"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

CMD Bioscience LLC has signed an exclusive licensing agreement with the Research Foundation of SUNY on behalf of Stony Brook University.

The deal gives CMD Bioscience exclusive control of a computational method for predicting protein-protein and protein-peptide binding affinities. The algorithm has enormous implications for computer-aided drug design.

“We are very excited about obtaining an exclusive license for this software from the Research Foundation of SUNY on behalf of Stony Brook University,” said Dr. Joseph Audie, the CEO and founder of CMD Bioscience. “This program gives us a competitive advantage and enhances our ability to rationally design proteins and peptides for our biotech and pharmaceutical partners.”

CMD Bioscience is a Connecticut-based company that uses proprietary computational methods to solve problems of biological and therapeutic interests. Formed in 2006, the company was founded by Dr. Joseph Audie of Meriden, CT., Ph.D.

Advertisement